Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
64 µM
Hemolytic
Cytotoxic
0% Hemolysis | 64 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020